These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 10108581)

  • 21. Medical devices; 30-day notices and 135-day PMA (premarket approval application) supplement review--FDA. Direct final rule.
    Fed Regist; 1998 Apr; 63(80 Pt 1):20530-3. PubMed ID: 10179319
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Current good manufacturing practice for blood and blood components; notification of consignees and transfusion recipients receiving blood and blood components at increased risk of transmitting hepatitis C virus infection ("lookback"). Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2007 Aug; 72(164):48765-801. PubMed ID: 17886394
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Medical devices; establishment registration and device listing for manufacturers and distributors of devices--FDA. Direct final rule.
    Fed Regist; 1998 Sep; 63(188):51825-7. PubMed ID: 10185812
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human tissue intended for transplantation--FDA. Interim rule; opportunity for public comment.
    Fed Regist; 1993 Dec; 58(238):65514-21. PubMed ID: 10131341
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Gloves: some unknowns].
    Checchi L; D'Achille C; Conti S
    Prev Assist Dent; 1991; 17(4):9-24. PubMed ID: 1784559
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The failure of the Food and Drug Administration to protect operating room personnel from the spread of deadly blood-borne infections.
    Edlich RF; Rhoads SK; Buck LR; Gubler KD; Long WB; Zura RB
    Ann Plast Surg; 2011 Apr; 66(4):421. PubMed ID: 21389804
    [No Abstract]   [Full Text] [Related]  

  • 27. Medical devices; current good manufacturing practice (CGMP) final fule; quality system regulation--FDA. Final rule.
    Fed Regist; 1996 Oct; 61(195):52602-62. PubMed ID: 10168287
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human cells, tissues, and cellular and tissue-based products; establishment registration and listing. Food and Drug Administration, HHS. Final rule.
    Fed Regist; 2001 Jan; 66(13):5447-69. PubMed ID: 11503777
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Medical devices; illustrative and designated lists for device tracking--FDA. Final rule and request for comments.
    Fed Regist; 1993 Aug; 58(156):43451-5. PubMed ID: 10171508
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Medical examination of aliens--removal of human immunodeficiency virus (HIV) infection from definition of communicable disease of public health significance. Final rule.
    Centers for Disease Control and Prevention (CDC), U.S. Department of Health and Human Services (HHS)
    Fed Regist; 2009 Nov; 74(210):56547-62. PubMed ID: 20166276
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Medical devices; establishment registration and device listing for manufacturers and distributors of devices; companion to direct final rule--FDA. Proposed rule.
    Fed Regist; 1998 Sep; 63(188):51874-5. PubMed ID: 10185813
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Medical devices; reports of corrections and removals; companion to direct final rule--FDA. Proposed rule.
    Fed Regist; 1998 Aug; 63(152):42300-4. PubMed ID: 10181727
    [TBL] [Abstract][Full Text] [Related]  

  • 33. FDA standardizes testing of AIDS workers' gloves.
    Public Health Rep; 1991; 106(2):217. PubMed ID: 1902317
    [No Abstract]   [Full Text] [Related]  

  • 34. Medical devices; 30-day notices and 135-day PMA (premarket approval application) supplement review; companion document to direct final rule--FDA. Proposed rule.
    Fed Regist; 1998 Apr; 63(80 Pt 1):20558-61. PubMed ID: 10179320
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Medical devices; reports of corrections and removals; lift of stay of effective date--FDA. Final rule; lift of stay of effective date.
    Fed Regist; 1998 Apr; 63(73):18836. PubMed ID: 10179315
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Testing for viral penetration of non-latex surgical and examination gloves: a comparison of three methods.
    O'Connell KP; El-Masri M; Broyles JB; Korniewicz DM
    Clin Microbiol Infect; 2004 Apr; 10(4):322-6. PubMed ID: 15059121
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Medical device reporting: manufacturer reporting, importer reporting, user facility reporting, and distributor reporting--FDA. Direct final rule.
    Fed Regist; 1998 May; 63(91):26069-77. PubMed ID: 10179334
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Barrier breach of surgical gloves.
    Beck WC
    J Long Term Eff Med Implants; 1994; 4(2-3):127-32. PubMed ID: 10155134
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Medical devices; medical device distributor reporting--FDA. Final rule; notification of status under the Safe Medical Devices Act; confirmation of effective date.
    Fed Regist; 1993 Sep; 58(168):46514-23. PubMed ID: 10128335
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Factors that impact on the infection control capability of gloves.
    Truscott W; Stoessel KB
    Prof Nurse; 2003 May; 18(9):507-11. PubMed ID: 12764958
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.